Routine laboratory data are decoupled from symptom phenotype and prognosis in Long COVID: within-cohort variation is dominated by age
Abstract Objectives Long COVID is defined by persistent multi-organ symptoms without an alternative diagnosis. This study evaluated whether routine laboratory data collected under real-world conditions differentiate symptom-defined subgroups within an outpatient cohort and predict the course. Methods In this single-center cohort study of 564 Long COVID patients (1,452 visits), symptom phenotypes were derived by latent class analysis of 19 organ-system domains at baseline. Structure in 89 routine analytes was sought by k-means clustering, confirmed with alternative algorithms, and repeated after age residualization. Analytes were compared across phenotypes using Kruskal-Wallis tests with false-discovery-rate control and adjustment for confounders. Equivalence testing was performed against reference change values. The course was modeled by count models. Prediction of improvement used a nested cross-validated elastic net with a baseline-independent endpoint. Results Clustering showed no convincing structure (silhouette ≤0.09, two to eight clusters); the weak split tracked age (50.5 vs. 38 years) and vanished after residualization. Three age-independent phenotypes (n=503) had no laboratory correlate: none of 89 analytes survived FDR correction, with or without adjustment, or across 50 pseudo-class draws. Equivalence held for 86/89 analytes within ±0.5 SD and 63/70 within the reference change value. Symptom burden declined (median 4 to 2 organ systems, p=2.5 × 10 −19 ); however, no analyte predicted the course (AUC 0.46). Conclusions Routine laboratory variation in this cohort was dominated by age and decoupled from symptom phenotype in both directions. Routine testing in a real-world setting could not provide an age-independent diagnostic, subtyping, or prognostic signature in a cohort of patients suffering from Long COVID.
Authors
- Thomas Szekeres (ORCID: https://orcid.org/0000-0003-4874-970X)
- Dominika Lukovic (ORCID: https://orcid.org/0000-0002-8040-8086)
- Ena Hašimbegović (ORCID: https://orcid.org/0000-0001-7544-7972)
- Thomas Perkmann (ORCID: https://orcid.org/0000-0002-7976-0285)
- Peter Quehenberger (ORCID: https://orcid.org/0000-0002-0122-8213)
- Laura Poschenreithner
- Emilie Han (ORCID: https://orcid.org/0000-0002-3064-1277)
- Viola Oberhauser
- Patrick Mucher (ORCID: https://orcid.org/0000-0002-0704-0940)
- Helmuth Haslacher (ORCID: https://orcid.org/0000-0003-4605-2503)
- Jutta K Bergler-Klein (ORCID: https://orcid.org/0000-0003-2591-1380)
- Oswald F Wagner
- Kevin Hamzaraj (ORCID: https://orcid.org/0000-0002-2505-8554)
- Lisbona Kastrati
- Monika Fritzer‐Szekeres
- Mariann Gyöngyösi
- Antonia Domanig (ORCID: https://orcid.org/0009-0000-4689-9996)
- Rodrig Marculescu-Ferrari
Institutions
- Medical University of Vienna (AT)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2026-10-12
- DOI
- https://doi.org/10.1515/cclm-2026-1238
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00